The DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Abstract
Breast cancer development largely depends upon the essential contributions from the tumor microenvironment, where several inflammatory cell populations (e.g. macrophages) orchestrate breast cancer development. The majority of tumor-associated macrophages (TAMs) exhibit alternatively activated M2 properties, produce abundant anti-inflammatory factors and facilitate tumor development. Clinical evidences compellingly indicate the association between high TAMs influx and poor prognosis in patients with breast cancers. The pan-macrophage marker CD68 is now generally utilized to identify TAMs in diagnostic biopsy samples, and some other TAM-related biomarkers are also utilized in prognosis prediction, including CD163, vascular endothelial growth factor (VEGF), hypoxia-inducible factors (HIFs), proliferating cellular nuclear antigen (PCNA), ferritin light chain (FTL) and C-C motif chemokine ligand 18 (CCL18). In this review, we highlight the recent progress made in understanding the relationship between TAMs and clinicopathological parameters in human breast cancer and address the potential value of TAMs as diagnostic and prognostic biomarkers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the appearance of tumor-supporting, iron-donating immune cells, in particular macrophages, is associated with tumor size and aggressiveness as well as poor patient prognosis [56,57].”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [56]
Citations
Cites
1 retracted
Yamamoto, N., Suyama, H., Yamamoto, N., & Ushijima, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.23107 · Cited by 62
RetractedExploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L. D., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,456
Breast cancer statistics, 2013
Desantis, C. E., Ma, J., Bryan, L. N., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,142
Ma, J., & Jemal, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,918
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Flagged first, then by citations
1 of the 92 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Laoui, 2011, Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions, Int. J. Dev. Biol., 55, 861, 10.1387/ijdb.113371dl · DOI
Cited by
Sorted by citations
Items 101–200 of 276
Ji, X., Peng, Z., Li, X., Yan, Z., Yang, Y., Zheng, Q., & Liu, Y. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.031 · Cited by 39
Distribution pattern of tumor associated macrophages predicts the prognosis of gastric cancer
Liu, J.-Y., Peng, C., Yang, G., Hu, W., Yang, X., Huang, C., Xiong, B., & Li, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21575 · Cited by 40
Moussawi, F. A., Kumar, A., Pasquereau, S., Tripathy, M. K., Karam, W. G., Diab‐Assaf, M., & Herbein, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-30109-1 · Cited by 39
High PTX3 expression is associated with a poor prognosis in diffuse large B‐cell lymphoma
Carreras, J., Kikuti, Y. Y., Hiraiwa, S., Miyaoka, M., Tomita, S., Ikoma, H., Ito, A., Kondo, Y., Itoh, J., Roncador, G., et al. (2021) · Cancer Science · doi:10.1111/cas.15179 · Cited by 39
Immunotherapy for breast cancer: past, present, and future
Spellman, A., & Tang, S.-C. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9654-9 · Cited by 39
Wang, S., Liu, X., Huang, R., Zheng, Y., Wang, N., Yang, B., Situ, H., Lin, Y. H., & Wang, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01371 · Cited by 37
Langford, D. J., Paul, S. M., West, C. M., Levine, J. D., Hamolsky, D., Elboim, C., Schmidt, B. L., Cooper, B. A., Abrams, G., Aouizerat, B. E., et al. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.08.014 · Cited by 38
Zhang, Y., Zhou, N., Yu, X., Zhang, X., Li, S., Lei, Z., Hu, R., Li, H., Mao, Y., Wang, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19320 · Cited by 37
Li, Y., Zhang, M., Zhang, S., Sun, X., Zhou, C., Li, J., Liu, J., Feng, J., Lu, S., Liu, P., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114423 · Cited by 38
Laidi, F., Bouziane, A., Lakhdar, A., Khabouze, S., Amrani, M., Rhrab, B., & Zaoui, F. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.11.4659 · Cited by 36
The Immune Microenvironment in Gastric Cancer: Prognostic Prediction
Ma, M., Sun, J., Liu, Z., Ouyang, S., Zhang, Z., Zeng, Z., Li, J., & Kang, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.836389 · Cited by 36
Li, L., Yang, L., Yang, S., Wang, R., Gao, H., Lin, Z., Zhao, Y., Tang, W., Han, R. F., Wang, W., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7578 · Cited by 36
Autophagy proteins regulate cell engulfment mechanisms that participate in cancer
Kim, S. E., & Overholtzer, M. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.004 · Cited by 35
“The presence of TAMs, like apoptotic index, correlates with poor prognosis for a number of carcinomas such as breast, prostate, and other types [33, 34].”
BackgroundBadr, N. M., Berditchevski, F., & Shaaban, A. M. (2019) · Pathobiology · doi:10.1159/000504055 · Cited by 35
Hassan, G., & Seno, M. (2020) · Cells · doi:10.3390/cells9051293 · Cited by 38
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
Conti, L., Ruiu, R., Barutello, G., Macagno, M., Bandini, S., Cavallo, F., & Lanzardo, S. (2014) · BioMed Research International · doi:10.1155/2014/534969 · Cited by 36
Harnessing the immune system for the treatment of breast cancer
Jiang, X. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300264 · Cited by 36
Mwafy, S. E., & El-Guindy, D. M. (2020) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-020-0018-8 · Cited by 34
Yang, T., Xu, F., Fang, D., & Chen, Y. (2015) · Scientific Reports · doi:10.1038/srep16733 · Cited by 34
Yuan, X., Ma, Y., Gao, R., Cui, S., Wang, Y., Fa, B., Ma, S., Wei, T., Ma, S., & Yu, Z. (2024) · Nature Communications · doi:10.1038/s41467-024-49846-1 · Cited by 31
Nan, H., Han, L., Ma, J., Yang, C., Su, R., & He, J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.031 · Cited by 33
The role of macrophages during breast cancer development and response to chemotherapy
Tao, S., Zhao, Z., Zhang, X., Guan, X., Wei, J., Yuan, B., He, S., Zhao, D., Zhang, J., Liu, Q.-D., et al. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02348-0 · Cited by 32
Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy
Živalj, M., Ginderachter, J. A. V., & Stijlemans, B. (2023) · Cancers · doi:10.3390/cancers15215159 · Cited by 35
Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis
Chen, X., Guo, C.-H., Wang, Z., Yang, Y., Pan, Y.-H., Liang, J.-Y., Sun, M.-G., Fan, L., Li, L., & Wang, W. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01450-4 · Cited by 32
Okła, K., Wertel, I., Polak, G., Surówka, J., Wawruszak, A., & Kotarski, J. (2016) · International Reviews of Immunology · doi:10.1080/08830185.2016.1206097 · Cited by 35
A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
Lin, F., Xiong, M., Wei, H., Song, Y., Liu, R., Yang, Y., Yuan, X., Fan, D., Zhang, Y., Hao, M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615534 · Cited by 32
Lin, T., Qiu, Y., Peng, W., & Peng, L. (2020) · BioMed Research International · doi:10.1155/2020/2148253 · Cited by 31
The immune-related gene CD52 is a favorable biomarker for breast cancer prognosis
Ma, Y., Chen, Y., Fang, D., Huang, Q., Luo, Z., Qin, Q., Lin, J., Zou, C., Huang, M., Meng, D., et al. (2021) · Gland Surgery · doi:10.21037/gs-20-922 · Cited by 30
Ji, H., Xuan, Q., Yan, M., Liu, T., Nanding, A., & Zhang, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.8993 · Cited by 29
Céspedes, M. V., Guillén, M. J., Lopez-Casas, P. P., Sarno, F., Gallardo, A., Álamo, P., Cuevas, C., Hidalgo, M. M., Galmarini, C. M., Allavena, P., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026369 · Cited by 29
Duhamel, M., Rose, M., Rodet, F., Murgoci, A., Zografidou, L., Régnier‐Vigouroux, A., Abeele, F. V., Kobeissy, F. H., Nataf, S., Pays, L., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000443 · Cited by 30
Shi, S., Chen, L., & Huang, G. (2013) · Medical Oncology · doi:10.1007/s12032-013-0698-1 · Cited by 27
Tu, Y. N., Tong, W. L., Samy, M. D., Yavorski, J. M., Kim, M., & Blanck, G. (2017) · International Journal of Cancer · doi:10.1002/ijc.30675 · Cited by 27
Separation of Macrophages Using a Dielectrophoresis-Based Microfluidic Device
Zhang, Y., Wang, S., Chen, J., Yang, F., & Li, G. (2020) · BioChip Journal · doi:10.1007/s13206-020-4207-2 · Cited by 28
4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory Responses
Madera, L., Greenshields, A. L., Coombs, M. R. P., & Hoskin, D. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133385 · Cited by 27
Kelly, M. G., Francisco, A. M. C., Cimic, A., Wofford, A., Fitzgerald, N., Yu, J., & Taylor, R. N. (2015) · Reproductive Sciences · doi:10.1177/1933719115570912 · Cited by 27
Wang, L., Wang, Y., Chen, L., & Ji, M. (2016) · Oncology Letters · doi:10.3892/ol.2016.5230 · Cited by 27
RetractedCytomegalovirus, Macrophages and Breast Cancer
Pasquereau, S., Moussawi, F. A., Karam, W. G., Assaf, M. D., Kumar, A., & Herbein, G. (2017) · The Open Virology Journal · doi:10.2174/1874357901711010015 · Cited by 27
Yasmin, A., Jha, R., Passi, A., Saha, P., Goyal, J., Jindal, S., & Goyal, K. (2025) · Biomarkers · doi:10.1080/1354750x.2025.2591717 · Cited by 26
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
Graversen, J. H., & Moestrup, S. K. (2015) · Membranes · doi:10.3390/membranes5020228 · Cited by 26
Han, L., Jia, Y., Song, Q., Wang, N., Wang, J., Bai, B., Chen, X.-L., Wang, C., & Cheng, Y. (2015) · Diseases of the Esophagus · doi:10.1111/dote.12401 · Cited by 26
Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
Zhang, M., Liu, K., & Wang, M. (2019) · RSC Advances · doi:10.1039/c9ra04590b · Cited by 26
Li, B., Yang, Q., Li, Z., Xu, Z., Sun, S., Wu, Q., & Sun, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.574787 · Cited by 25
Arole, V., Nitta, H., Wei, L., Shen, T., Parwani, A. V., & Li, Z. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06260-1 · Cited by 25
Xu, X., Wan, J., Yuan, L., Ba, J., Feng, P., Long, W., Huang, H., Liu, P., Cai, Y., Liu, M., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5453-8 · Cited by 25
Zhang, P., Yang, Y., Qian, K., Li, L., Zhang, C., Fu, X., Zhang, X., Chen, H., Liu, Q., Cao, S., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010759 · Cited by 25
Wang, S., Jiang, H., Zheng, C., Gu, M., & Zheng, X. (2022) · BMC Cancer · doi:10.1186/s12885-021-09150-3 · Cited by 24
Maisel, B. A., Yi, M., Peck, A. R., Sun, Y., Hooke, J. A., Kovatich, A. J., Shriver, C. D., Hu, H., Nevalainen, M. T., Tanaka, T., et al. (2022) · Cancers · doi:10.3390/cancers14020308 · Cited by 24
Liu, H., Wang, J., Liu, Z., Wang, L., Liu, S., & Zhang, Q. (2017) · Medicine · doi:10.1097/md.0000000000006663 · Cited by 23
Lu, Y., Guo, L., & Ding, G. (2019) · Future Oncology · doi:10.2217/fon-2019-0519 · Cited by 23
Locally Targeting the IL-17/IL-17RA Axis Reduced Tumor Growth in a Murine B16F10 Melanoma Model
Chen, Y.-S., Huang, T., Liu, C., Chen, H., Lee, M.-H., Chen, H., & Shen, C. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.104 · Cited by 23
Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence
Chen, X.-Y., Thike, A. A., Nasir, N. D. M., Koh, V. C. Y., Bay, B., & Tan, P. H. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02735-1 · Cited by 21
Peng, L., Wang, Y., Fei, S., Wei, C., Tong, F., Wu, G., Ma, H., & Dong, X. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-500 · Cited by 22
Qi, Q., Ji, H., Li, D., Zhang, H., Zhang, Z., & Zhang, Q. (2021) · Neoplasma · doi:10.4149/neo_2021_201226n1404 · Cited by 22
Yin, Y., Zhang, Y., Li, L., Zhang, S., Liu, N., & Yuan, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650980 · Cited by 21
Ding, X., Zhang, J., Shi, M., Liu, D., Zhang, L., Zhang, R., Su, B., & Ai, K. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02392-w · Cited by 21
da Silva, S. D., Marchi, F. A., Su, J., Yang, L., Valverde, L. D. F., Hier, J., Bijian, K., Hier, M., Mlynarek, A., Kowalski, L. P., et al. (2021) · Cancers · doi:10.3390/cancers13010153 · Cited by 22
Inflammatory Cell Distribution in Primary Merkel Cell Carcinoma
Wheat, R. L., Roberts, C., Waterboer, T., Steele, J. C., Marsden, J., Steven, N. M., & Blackbourn, D. J. (2014) · Cancers · doi:10.3390/cancers6021047 · Cited by 21
Identification of a novel macrophage-related prognostic signature in colorectal cancer
Lin, D., Zheng, T., Huang, S., Hua, S., Liu, R., Guan, S., & Zhang, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-53207-9 · Cited by 20
Ferritin as an Effective Prognostic Factor and Potential Cancer Biomarker
Szymulewska-Konopko, K., Reszeć-Giełażyn, J., & Małeczek, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47010060 · Cited by 27
Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression
Li, Y., Ganesan, K., & Chen, J. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220520121711 · Cited by 20
Wenger, R. H., Fuady, J. H., Bordoli, M. R., Abreu‐Rodríguez, I., Kristiansen, G., Hoogewijs, D., & Stiehl, D. P. (2014) · Hypoxia · doi:10.2147/hp.s54404 · Cited by 19
Wang, J.-B., Gao, Y.-X., Ye, Y., Lin, T.-X., Li, P., Lin, J., Chen, Q., Cao, L., Lin, M., Tu, R., et al. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00515-9 · Cited by 19
CCL2-Mediated Stromal Interactions Drive Macrophage Polarization to Increase Breast Tumorigenesis
Archer, M., Bernhardt, S. M., Hodson, L. J., Woolford, L., der Hoek, M. B. V., Dasari, P., Evdokiou, A., & Ingman, W. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087385 · Cited by 19
Cuenca-Micó, O., Delgado-González, E., Anguiano, B., Vaca‐Paniagua, F., Medina-Rivera, A., Rodríguez‐Dorantes, M., & Aceves, C. (2021) · Biomolecules · doi:10.3390/biom11101501 · Cited by 18
Effect of metabolism on the immune microenvironment of breast cancer
Zhou, Y., Wang, H., Luo, Y., Tuo, B., Liu, X., & Li, T. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188861 · Cited by 19
Shinohara, H., Kobayashi, M., Hayashi, K., Nogawa, D., Asakawa, A., Ohata, Y., Kubota, K., Takahashi, H., Yamada, M., Tokunaga, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113235 · Cited by 17
Wang, Y., Wang, H., Yin, W., Lin, Y., Zhou, L., Sheng, X., Xu, Y., Sha, R., & Lu, J. (2019) · Gland Surgery · doi:10.21037/gs.2019.10.10 · Cited by 17
Huang, L., Qin, S., Xia, L., Ma, F., & Chen, L. (2023) · Cancer Medicine · doi:10.1002/cam4.5892 · Cited by 16
Chang, W., Yen, M., Hung, J., Yang, C., Jian, S., Yeh, I., Liu, K., Hsu, Y., & Kuo, P. (2017) · Oncology Reports · doi:10.3892/or.2017.6141 · Cited by 15
Wang, S., Zhou, Z., Tian, D., Huang, S., Wang, C., Gao, Z., Ben, X., Tang, J., Xie, L., Zhou, H., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-1628 · Cited by 15
Impact of Immune Cell Heterogeneity on HER2+ Breast Cancer Prognosis and Response to Therapy
Perrone, M., Talarico, G., Chiodoni, C., & Sangaletti, S. (2021) · Cancers · doi:10.3390/cancers13246352 · Cited by 17
An isoform of AIF1 involved in breast cancer
Slim, F. A., Ouellette, G., Ennour‐Idrissi, K., Jacob, S., Diorio, C., & Durocher, F. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0663-3 · Cited by 18
Ju, M., Tong, W., Bi, J., Zeng, X., Qi, A., Sun, M., Wen, J., Zhao, L., & Wei, M. (2025) · Advanced Science · doi:10.1002/advs.202413607 · Cited by 15
Wagner, T. R., Blaess, S., Leske, I. B., Frecot, D. I., Gramlich, M., Traenkle, B., Kaiser, P. D., Seyfried, D., Maier, S. M., Rezza, A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1264179 · Cited by 14
Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer
Avilés‐Jurado, F. X., Terra, X., Gómez, D., Flores, J. C., Raventós, A., Maymó‐Masip, E., León, X., Serrano-Gonzalvo, V., Vendrell, J. J., Figuerola, E., et al. (2014) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-014-3095-2 · Cited by 15
PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer
Liu, B., Xiao, X., Lin, Z., Lou, Y., & Zhao, L. (2021) · Cancer Biomarkers · doi:10.3233/cbm-210335 · Cited by 14
Badowska-Kozakiewicz, A. M., Budzik, M. P., & Przybylski, J. (2016) · Polish Journal of Pathology · doi:10.5114/pjp.2015.57245 · Cited by 14
Chen, X., Wu, J., Zhang, F., Ying, L., & Chen, Y. (2017) · Laboratory Medicine · doi:10.1093/labmed/lmx069 · Cited by 14
Multifunctional Role of Lipids in Modulating the Tumorigenic Properties of 4T1 Breast Cancer Cells
He, Y., Rezaei, S., Júnior, R. F. D. A., Cruz, L. J., & Eich, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084240 · Cited by 14
When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer
Lapeire, L., Denys, H. G., Cocquyt, V., & Wever, O. D. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0018 · Cited by 16
Xu, S., Gu, Z., Lu, H., Guan, P., & Liu, Z. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c03950 · Cited by 13
FTL: a novel predictor in gastric cancer.
Zhang, L., Chen, Z., & Xu, A. (2017) · PubMed Central · Cited by 13
Liu, Y., Lin, T., Chong, K., Chen, G.-Y., Kuo, C.-Y., Lin, Y.-Y., Chang, C.-W., Hsiao, T., Wang, C.-L., Shih, Y.-C., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02010-0 · Cited by 12
Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth
Xuan, Z., Li, L., Zhang, Q., Xu, C., Yang, D., Yuan, Y., An, Y., Wang, S., Li, X., & Yuan, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2690 · Cited by 11
Li, Y., Li, M., Wei, R., & Wu, J. (2020) · Journal of Immunology Research · doi:10.1155/2020/9374240 · Cited by 12
Chen, X.-Y., Thike, A. A., Koh, V. C. Y., Nasir, N. D. M., Bay, B., & Tan, P. H. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02959-6 · Cited by 11
Tatsuno, R., Komohara, Y., Pan, C., Kawasaki, T., Enomoto, A., Jubashi, T., Kono, H., Wako, M., Ashizawa, T., Haro, H., et al. (2024) · Cancers · doi:10.3390/cancers16162801 · Cited by 10
Wolf, M., Brochhausen, C., Ramakrishnan, V., Iberl, S., Roth, J., Seitz, S., Burkhardt, R., & Stadler, S. C. (2024) · Cancers · doi:10.3390/cancers16203515 · Cited by 11
Obeagu, E. I., & Ezeala, C. C. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003269 · Cited by 11
Kwon, H., Han, H., Oh, Y., Kim, Y., & Kim, J. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04968-x · Cited by 13
Zeng, L., Koh, V. C. Y., Chen, X., & Tan, P. H. (2023) · Histopathology · doi:10.1111/his.14865 · Cited by 11
Characterization of Hyaluronan Localization in the Developing Mammary Gland and Mammary Tumors
Witschen, P. M., Elfstrum, A. K., Nelson, A., & Schwertfeger, K. L. (2023) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-023-09528-y · Cited by 10
Soni, S. S., D’Elia, A. M., & Rodell, C. B. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01290-2 · Cited by 11
An obligatory anaerobic Salmonella�typhimurium strain redirects M2 macrophages to the M1 phenotype
Yang, M., Xu, J., Wang, Q., Zhang, A., & Wang, K. (2018) · Oncology Letters · doi:10.3892/ol.2018.7742 · Cited by 10
Toner, Y. C., Prévot, G., van Leent, M. M. T., Munitz, J., Oosterwijk, R. S., Verschuur, A. V. D., van Elsas, Y., Peric, V., Maas, R. J. F., Ranzenigo, A., et al. (2024) · npj Imaging · doi:10.1038/s44303-024-00009-3 · Cited by 9
Macrophages as Potential Therapeutic Targets in Acute Myeloid Leukemia
Mesaros, O., Onciul, M., Matei, E., Joldes, C., Jimbu, L., Neaga, A., Serban, O., Zdrenghea, M., & Nanut, A. M. (2024) · Biomedicines · doi:10.3390/biomedicines12102306 · Cited by 11
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer
Lee, S., Cho, Y., Li, Y., Li, R., Lau, A. W., Laird, M. S., Brown, D. D., McAuliffe, P. F., Lee, A. V., Oesterreich, S., et al. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2429186 · Cited by 10
Zhang, W.-W., Rong, Y., Liu, Q., Luo, C.-L., Zhang, Y., & Wang, F. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-02004-8 · Cited by 10
Li, M., Zhao, Y., Liu, X., Shuan, Z., Jiang, Y., & Yang, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11423 · Cited by 9
Metadata
- Authors
- Tang, X.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Tang, Xiaoqiang
- ORCID
- Tang, Xiaoqiang
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 332
- Issue
- 1
- Pages
- 3-10
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2077731584
- Cited by
- 276
- References
- 92
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 24 · 2023: 20 · 2022: 21 · 2021: 20 · 2020: 30 · 2019: 24 · 2018: 21 · 2017: 26 · 2016: 16 · 2015: 24 · 2014: 27 · 2013: 9
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tsinghua University
- West China Hospital, Sichuan University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor-associated macrophages, breast cancer, tumor microenvironment, M2 macrophages, CD68, prognostic factors, diagnostic biomarkers, CD163, vascular endothelial growth factor, hypoxia-inducible factor, PCNA, ferritin light chain, CCL18, TAM infiltration
- MeSH terms
- CD68 Molecule, Animals, Biopsy, Breast Neoplasms, Female, Humans, Macrophages, Predictive Value of Tests, Prognosis, Biomarkers, Tumor, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review